` Comparison: 20B, NTRA - Alpha Spread

B
20B
vs
NTRA

Over the past 12 months, 20B has significantly outperformed NTRA, delivering a return of +84% compared to the NTRA's +32% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
20B
NTRA
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

B
20B Intrinsic Value
0.004 EUR
Overvaluation 98%
Intrinsic Value
Price
NTRA Intrinsic Value
72.96 USD
Overvaluation 53%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
B
BioMark Diagnostics Inc
SWB:20B
0.234 EUR
Natera Inc
NASDAQ:NTRA
156.54 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
20B, NTRA

20B
NTRA
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
B
BioMark Diagnostics Inc
Revenue
Natera Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
20B, NTRA

20B
NTRA
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
B
BioMark Diagnostics Inc
SWB:20B
Natera Inc
NASDAQ:NTRA
What is Free Cash Flow?

Gross Margin

20B
0%
NTRA
61.8%
LTM 3Y Avg 5Y Avg 10Y Avg
B
BioMark Diagnostics Inc
Natera Inc

Operating Margin

20B
-1 260%
NTRA
-12.4%
LTM 3Y Avg 5Y Avg 10Y Avg
B
BioMark Diagnostics Inc
Natera Inc

Net Margin

20B
-1 223.7%
NTRA
-10.4%
LTM 3Y Avg 5Y Avg 10Y Avg
B
BioMark Diagnostics Inc
Natera Inc

FCF Margin

20B
-554.4%
NTRA
4.7%
LTM 3Y Avg 5Y Avg 10Y Avg
B
BioMark Diagnostics Inc
Natera Inc

ROE

20B
228.8%
NTRA
-18.7%
LTM 3Y Avg 5Y Avg 10Y Avg
B
BioMark Diagnostics Inc
Natera Inc

ROA

20B
-170.4%
NTRA
-11.9%
LTM 3Y Avg 5Y Avg 10Y Avg
B
BioMark Diagnostics Inc
Natera Inc

ROIC

20B
-308.3%
NTRA
-36.1%
LTM 3Y Avg 5Y Avg 10Y Avg
B
BioMark Diagnostics Inc
Natera Inc

ROCE

20B
594.4%
NTRA
-18%
LTM 3Y Avg 5Y Avg 10Y Avg
B
BioMark Diagnostics Inc
Natera Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
20B, NTRA

Loading

Performance Gap
20B, NTRA

Loading
20B
NTRA
Difference
www.alphaspread.com

Performance By Year
20B, NTRA

Loading
20B
NTRA
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 20B to other stocks
Unlock Full Access to Alpha Spread
Create Free Account